Nattokinase and arterial plaque: what the evidence supports

By Marcus Renshaw · · updated

I added nattokinase to my stack for a narrow reason: to fill the one gap nothing else in it covered, clot risk. I run compounds that can nudge clotting the wrong way, and nattokinase is the rare supplement with a real fibrinolytic mechanism, so I titrated a delayed release form up to 10,800 FU a day over a few weeks rather than starting at the top. That is the honest version of why it is there. The louder version, the one that says it dissolves plaque better than a statin, does not survive a look at the actual study.

Nattokinase is an enzyme from fermented soybeans that breaks down fibrin, the protein scaffold of a clot. Small randomized trials show a modest blood pressure drop, and one large retrospective study links a high dose to carotid plaque regression. It is a fibrinolytic layer, not a statin replacement, and it raises bleeding risk when stacked with anything that thins the blood.

What is nattokinase and what does it actually do?

Nattokinase is a serine protease, an enzyme extracted from natto, the fermented soybean dish. Its job is fibrinolysis: breaking down fibrin, the mesh of protein that holds a blood clot together. It does this two ways. It cleaves fibrin directly, and in lab assays it degrades cross-linked fibrin several times faster than plasmin, the body’s own clot-dissolving enzyme. It also works indirectly, by lowering PAI-1 and boosting tissue plasminogen activator, which is the switch that turns the body’s plasminogen into active plasmin.

The short version: it is one of the few oral supplements with a plausible, well-described antithrombotic mechanism rather than a vague “supports circulation” claim. That mechanism is also exactly why the safety section below matters.

What did the carotid plaque study really find?

This is the study everyone cites, and it is worth reading honestly. A 2022 clinical study of 1,062 participants took nattokinase at 10,800 FU a day for 12 months and measured the carotid arteries by ultrasound. The results are striking on their face: average intima-media thickness fell from 1.33 to 1.04 mm, roughly a 22% reduction, and carotid plaque size dropped by up to 36%. Lipids improved alongside it, with LDL down about 18%. A lower 3,600 FU dose did nothing, which tells you the dose is load bearing.

Now the part the supplement pages leave out. It was a retrospective study, not a randomized controlled trial. That is a real limitation, not a footnote. People who chose to take nattokinase for a year may differ from those who did not in diet, discipline, and a dozen other things a retrospective design cannot control for. And despite what half the internet repeats, there was no simvastatin arm in this study, so it did not “beat a statin.” It compared nattokinase doses to each other. What it honestly shows is a strong association between a high dose and plaque regression, in one population, that has not yet been confirmed by the kind of trial that could prove cause. That is a genuine signal worth acting on cautiously, not settled proof.

Does nattokinase lower blood pressure?

Here the evidence is weaker but cleaner, because it comes from randomized trials. A 2024 meta-analysis of six randomized controlled trials found nattokinase lowered systolic blood pressure by about 3.45 mmHg and diastolic by about 2.32 mmHg against placebo. A North American trial also saw reduced von Willebrand factor, a clotting-related marker, alongside the blood pressure drop.

Those numbers are small, on the order of what a modest lifestyle change buys you, and the longest trial did not confirm a lasting effect. So this is not a blood pressure treatment. It is a minor push in the right direction that only means anything if you are actually measuring your blood pressure properly and watching the trend, rather than trusting a single reading to tell you it worked.

The catch: bleeding risk and what it stacks with

An enzyme that dissolves fibrin does not know the difference between a dangerous clot and the clot you need after a cut or during surgery. Taken alone at studied doses up to 10,800 FU a day, nattokinase has a clean safety record with no serious bleeding in the large trials. The problem is stacking.

Combined with an anticoagulant like warfarin or a DOAC, an antiplatelet drug, or even daily aspirin, nattokinase adds to the bleeding risk, and there are documented case reports of serious bleeding, including a fatal one on nattokinase alone. Fish oil at high doses pulls the same direction. So does more of the self-experimenter toolkit than people realize. The standard guidance is consistent: do not combine it with blood thinners without a clinician in the loop, never substitute it for a prescribed anticoagulant, and stop it about two weeks before any surgery or dental work. The full version, the specific interactions, the case reports, and who should avoid it entirely, is in nattokinase bleeding risk. This is the one supplement where “it’s natural, so it’s harmless” can actually put you in the emergency room.

Where does nattokinase fit a self-experimenter’s stack?

Nattokinase is not a guideline drug, so the clinical literature will not hand you a target or a protocol. If you are building your own stack, the honest role it plays is a fibrinolytic layer for a specific reason, not a general “heart health” capsule. The clearest case is when the rest of your protocol nudges clotting risk upward, which several performance and hormone compounds quietly do, and you want something working the other way.

Give it a job, the same test as any supplement you are deciding whether to keep. The job here is antithrombotic support, and the two things you can actually watch are your blood pressure trend and, less quantifiably, any sign of easy bruising or bleeding. Titrate the dose up rather than starting high, and use a delayed release or enteric form, which is meant to survive stomach acid rather than being broken down before it can act. Budget is not the constraint, it is cheap. The constraint is the interaction list, which is why this is a conversation to have with a clinician before you start, not after, especially if anything else you take thins the blood. None of this is medical advice, and the bleeding-risk stacking is real enough that a clinician and honest disclosure of your full stack are not optional here.

That interaction problem is the entire reason the supplement journal in the Operating System bundle asks for a job and an interaction note beside each item, not just a name and a dose. An enzyme that thins your blood sitting three rows above a fish oil and an aspirin is the kind of stack collision you want visible in one place, next to the blood pressure trend it is supposed to move. The tools that read your ApoB and Lp(a) tell you the risk; this is about tracking what you take against it.

If you are considering nattokinase, write down the one job you want it doing, list everything else you take that touches clotting, and take that list to a clinician before the first dose. Then watch your blood pressure trend, because it is the one effect you can measure at home.

FAQ

What does nattokinase do?

It is a fibrinolytic enzyme from fermented soybeans that breaks down fibrin, the protein that forms the structure of a blood clot. It acts directly on fibrin and also indirectly by boosting the body’s own clot-dissolving pathway. That antithrombotic mechanism is well described, which sets it apart from supplements that claim vague circulatory benefits without one.

Can nattokinase clear arterial plaque?

There is one striking study, but read it carefully. A 2022 retrospective study of 1,062 people on 10,800 FU a day for a year found carotid plaque dropped by up to 36% and artery wall thickness fell about 22%. Because it was retrospective rather than a randomized trial, it shows a strong association, not proof of cause. Promising, not settled.

Does nattokinase lower blood pressure?

Modestly. A 2024 meta-analysis of six randomized trials found it lowered systolic pressure by about 3.45 and diastolic by about 2.32 mmHg versus placebo. That is roughly what a small lifestyle change delivers, and the longest trial did not confirm a lasting effect. It is a minor push, not a blood pressure treatment.

Is nattokinase safe?

Taken alone at the doses studied, up to 10,800 FU a day, it has a clean safety record with no serious bleeding in trials of over a thousand people. The risk is not the enzyme by itself, it is combining it with anything else that thins the blood, where the bleeding risks add together.

Can you take nattokinase with aspirin or blood thinners?

Not without medical guidance. Combined with warfarin, a DOAC like apixaban or rivaroxaban, an antiplatelet drug, or even daily aspirin, nattokinase adds to bleeding risk. Do not substitute it for a prescribed anticoagulant, and stop it roughly two weeks before any surgery or dental procedure. Fish oil at high doses pushes the same direction.

What dose of nattokinase is used in studies?

Blood pressure trials mostly used around 2,000 FU a day. The carotid plaque study used 10,800 FU a day, and a lower 3,600 FU dose showed no effect in the same study, so the dose appears to matter. FU stands for fibrinolytic units, which is the activity measure to look for on a label rather than milligrams.

Is nattokinase a replacement for a statin?

No. Despite a common claim online, the plaque study had no statin comparison arm, so it never showed nattokinase beating one. Statins have large randomized outcome trials behind them; nattokinase does not. Treat nattokinase as a possible antithrombotic layer, not a substitute for a drug your clinician prescribed.

Sources